UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impairment in Pure and Comorbid Generalized Anxiety Disorder and Major Depression at 12 Months in Two National Surveys

The American journal of psychiatry, 1999-12, Vol.156 (12), p.1915-1923

1999

Volltextzugriff (PDF)

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder

The journal of clinical psychiatry, 1999-08, Vol.60 (8), p.528-535

1999

Volltextzugriff (PDF)

TWELVE-STEP AND MUTUAL-HELP PROGRAMS FOR ADDICTIVE DISORDERS

The Psychiatric clinics of North America, 1999-06, Vol.22 (2), p.425-446

1999

Volltextzugriff (PDF)

Drug testing by urine and hair analysis: complementary features and scientific issues

Forensic science international, 1995-01, Vol.70 (1), p.63-76

1995

Volltextzugriff (PDF)

Drug legalization, harm reduction, and drug policy

Annals of internal medicine, 1995-09, Vol.123 (6), p.461

1995

Volltextzugriff (PDF)

Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States

BMJ, 2008-11, Vol.337 (7679), p.a2038-a2038

International edition, 2008

Volltextzugriff (PDF)

The Opioid Epidemic is an Historic Opportunity to Improve Both Prevention and Treatment

Brain research bulletin, 2018-04, Vol.138, p.112-114

DuPont, Robert L

2018

Volltextzugriff (PDF)

The Origins of the Minnesota Model of Addiction Treatment-A First Person Account

Journal of addictive diseases, 1999-03, Vol.18 (1), p.107-114

1999

Volltextzugriff (PDF)

Biology and the Environment-Rethinking Demand Reduction

Journal of addictive diseases, 1999-12, Vol.18 (4), p.121-138

Dupont, Robert L.

1999

Volltextzugriff (PDF)

Addiction: a new paradigm

Bulletin of the Menninger Clinic, 1998-03, Vol.62 (2), p.231

DuPont, R L

1998

Volltextzugriff (PDF)

The war on drugs

The New England journal of medicine, 1994-07, Vol.331 (2), p.128; author reply 128

DuPont, R L

1994

Volltextzugriff (PDF)

Alprazolam and benzodiazepine dependence

The journal of clinical psychiatry, 1993-10, Vol.54 Suppl, p.64

1993

Volltextzugriff (PDF)

Controlled Substances in the Polydrug Epidemic: Response to Diller

The American journal of psychiatry, 2019-01, Vol.176 (1), p.78-78

2019

Volltextzugriff (PDF)

Examining the Debate on the Use of Medical Marijuana

Proceedings of the Association of American Physicians, 1999-03, Vol.111 (2), p.166-172

DuPont, Robert L.

1999

Volltextzugriff (PDF)

Thinking about stopping treatment for panic disorder

The journal of clinical psychiatry, 1990-12, Vol.51 Suppl A, p.38

DuPont, R L

1990

Volltextzugriff (PDF)

Anxiety and addiction: a clinical perspective on comorbidity

Bulletin of the Menninger Clinic, 1995, Vol.59 (2 Suppl A), p.A53

DuPont, R L

1995

Volltextzugriff (PDF)

The Mirage of Impairing Drug Concentration Thresholds: A Rationale for Zero Tolerance Per Se Driving under the Influence of Drugs Laws

Journal of analytical toxicology, 2012-06, Vol.36 (5), p.353-356

2012

Volltextzugriff (PDF)

Medicinal Marijuana?

The New England journal of medicine, 1997-04, Vol.336 (16), p.1184-1187

1997

Volltextzugriff (PDF)

Prescription Drug Abuse: An Epidemic Dilemma

Journal of psychoactive drugs, 2010-06, Vol.42 (2), p.127-132

DuPont, Robert L.

2010

Volltextzugriff (PDF)

Medicines and Drug Testing in the Workplace

Journal of psychoactive drugs, 1990-10, Vol.22 (4), p.451-459

DuPont, Robert L.

1990

Volltextzugriff (PDF)

Can Drug Design Inhibit Abuse?

Journal of psychoactive drugs, 2005-12, Vol.37 (4), p.343-362

2005

Volltextzugriff (PDF)

Prevention of Adolescent Chemical Dependency

The Pediatric clinics of North America, 1987-04, Vol.34 (2), p.495-505

DuPont, Robert L.

1987

Volltextzugriff (PDF)

Discontinuation of alprazolam after long-term treatment of panic-related disorders

Journal of clinical psychopharmacology, 1992-10, Vol.12 (5), p.352-354

1992

Volltextzugriff (PDF)

Drug test results as a predictor of retention among patients using buprenorphine in a comprehensive outpatient treatment program

Journal of addictive diseases, 2016-10, Vol.35 (4), p.315-324

2016

Volltextzugriff (PDF)

Prescription drugs, drugged driving and per se laws

Injury prevention, 2013-06, Vol.19 (3), p.218-221

2013

Volltextzugriff (PDF)

1 – 25 von 2.439

Menü

Weitere Dienste

Einstellungen

Impairment in Pure and Comorbid Generalized Anxiety Disorder and Major Depression at 12 Months in Two National Surveys

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder

TWELVE-STEP AND MUTUAL-HELP PROGRAMS FOR ADDICTIVE DISORDERS

Drug testing by urine and hair analysis: complementary features and scientific issues

Drug legalization, harm reduction, and drug policy

Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States

The Opioid Epidemic is an Historic Opportunity to Improve Both Prevention and Treatment

The Origins of the Minnesota Model of Addiction Treatment-A First Person Account

Biology and the Environment-Rethinking Demand Reduction

Addiction: a new paradigm

The war on drugs

Alprazolam and benzodiazepine dependence

Controlled Substances in the Polydrug Epidemic: Response to Diller

Examining the Debate on the Use of Medical Marijuana

Thinking about stopping treatment for panic disorder

Anxiety and addiction: a clinical perspective on comorbidity

The Mirage of Impairing Drug Concentration Thresholds: A Rationale for Zero Tolerance Per Se Driving under the Influence of Drugs Laws

Medicinal Marijuana?

Prescription Drug Abuse: An Epidemic Dilemma

Medicines and Drug Testing in the Workplace

Can Drug Design Inhibit Abuse?

Prevention of Adolescent Chemical Dependency

Discontinuation of alprazolam after long-term treatment of panic-related disorders

Drug test results as a predictor of retention among patients using buprenorphine in a comprehensive outpatient treatment program

Prescription drugs, drugged driving and per se laws

Aktive Filter

Suchergebnisse filtern